维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="PASSLER T"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Control of bo- vine viral diarrhea virus in ruminants 显示文摘	Walz P H Grooms D L Passler T	2010	J Vet Intern Med2010，24，3：	1
	2	Control of bovine viral diarrhea virus in ruminants显示文摘	Walz P H Grooms D L Passler T	2010	J Vet Intern Med2010，24，3：	1
	3	Control of bovine viral diarrhea virus in ruminants显示文摘	Walz P H Grooms D L Passler T	2010	J Vet Intern Med2010，24，3：	1
	4	Control of bovine vi- ral diarrhea virus in ruminants显示文摘	Walz P H Grooms D L Passler T	2010	J Vet Intern Med2010，24，3：	1
	5	Control of bovine viral diarrhea virus in ruminants 显示文摘	WALZ P H GROOMS D L PASSLER T	2010	J Vet Intern Med2010，24，3：	1
	6	Experimental persis- tent infection with bovine viral diarrhea virus in white-tailed deer 显示文摘	Passler T Walz P H Ditchkoff S S	2007	Vet Microbiol2007，122，3：	1
	7	Control of bo-vine viral diarrhea virus in ruminants显示文摘	WALZ P H GROOMS D L PASSLER T	2010	J Vet Intern Med2010，24，3：	1
	8	Erzeugung Stabilisierung und Reaktivit:it des Silaethens显示文摘	Wiberg N Passler T Polborn K	1997	J Organomet Chem1997，531，1：	1
	9	Pseudo-or real progression? An ovarian cancer patient under nivolumab:A case report显示文摘BACKGROUND Checkpoint-Inhibition has revolutionized the treatment for several entities such as melanoma and renal cell carcinoma.The first encouraging experience in ovarian cancer was reported for nivolumab,a fully humanized anti-programmed death-1 antibody.Pseudoprogression is a new phenomenon associated with these novel immuno-oncologic agents.It can be explained by infiltrating leucocytes and edema that result in a temporary increase in tumor size and delayed subsequent shrinkage due to tumor cell destruction.CASE SUMMARY We report on a 47-year old patient with platinum-resistant ovarian cancer that was treated off-label with nivolumab 3mg/kg iv d1q14d.She first experienced classic pseudoprogression with inguinal lymph node swelling after cycle two and subsequent shrinkage.After 6 cycles she presented with rectal bleeding and progressive disease was diagnosed due to new tumor infiltration into the rectum.CONCLUSION Clinicians should be aware of pseudoprogression,its underlying mechanisms and strategies to discriminate pseudo-from real progression in ovarian cancer.	Mona Passler Eliane T Taube Jalid Sehouli Klaus Pietzner	2019	World Journal of Clinical Oncology2019，10，7：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费